pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
← back to Ophthalmology
News · Ophthalmology
406
stories
Sep 8, 26
Reynolds is selling fruity new vapes unauthorized by FDA
stat
Sep 6, 26
AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapies
fiercebiotech
Sep 5, 26
Novartis, Ionis drug failure spurs questions about an emerging class of heart medicines
biopharma dive
Sep 5, 26
Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and more
stat
Sep 4, 26
Disabled workers at greater risk of losing health insurance
stat
Sep 3, 26
Fi Recalls Supplements for Dogs Because of Possible Salmonella Contamination
fda recalls
Sep 3, 26
STAT+: Fauci speaks, and writes
stat
Sep 3, 26
STAT+: OpenEvidence launches new family of AI models
stat
Sep 3, 26
Capricor, Replimune illustrate why FDA must listen to rare disease specialists
biospace
Sep 2, 26
SEC, FDA sign info-sharing agreement as a ‘signal to the market’ on insider trading
fiercebiotech
Sep 1, 26
STAT+: FDA clears Stryker’s ‘surgical cockpit’ that uses Apple’s VR headset, Vision Pro
stat
Sep 1, 26
K Health is eyeing an IPO by 2029
endpoints
Aug 31, 26
Lilly adds to immune drug pipeline with $2.9B Merida buyout
biopharma dive
Aug 31, 26
Deal-hungry Lilly strikes up to $2.9B immuno play for Merida
biospace
Aug 31, 26
The next frontier: Advancing foundation models with multimodal data
biopharma dive
Aug 31, 26
Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies
fiercebiotech
Aug 29, 26
Northwest Naturals Voluntarily Recalls Two Raw Pet Food Products Because of Possible Salmonella & Listeria Monocytogenes Health Risk
fda recalls
Aug 28, 26
FDA green lights Priovant drug for rare skin disease
biopharma dive
Aug 27, 26
Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company.
biopharma dive
Aug 27, 26
Osivax bags flu vaccine rights to pursue combination shot vision
fiercebiotech
Aug 26, 26
Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trial
biopharma dive
Aug 26, 26
CDMO hiring tough as demand for specialized talent outpaces supply
biospace
Aug 25, 26
Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail
biospace
Aug 24, 26
Bausch + Lomb plans Phase 3 trial for dry eye drop, despite missing mid-stage goal
endpoints
Aug 24, 26
Qiagen appoints new chief executive after 9-month search
fiercebiotech
Aug 24, 26
TME holds onto $1B dream for brain cancer drug as search for partners nears conclusion
fiercebiotech
Aug 21, 26
STAT+: HHS document offers new clues to Kennedy’s vaccine plans
stat
Aug 20, 26
Regeneron to challenge Ipsen as FDA clears bone disease drug
biopharma dive
Aug 20, 26
Contrasting legal decisions on gender-affirming care
stat
Aug 20, 26
Opinion: The global health aid architecture is collapsing. The faith economy isn’t
stat
← prev
page 8 of 14
next →
Ophthalmology · news · pharmadog